Startups

Barts Charity

London, United Kingdom

bartscharity.org.uk

find-and-update.company-information.service.gov.uk

Barts Charity is an independent London charitable company funding health research and improvements to healthcare for people in East London. The exact legal entity is Barts Charity, Companies House07168381, and registered charity212563. The corporate vehicle was incorporated February24,2010; its charitable registration and predecessor hospital-charity history predate that legal company, so no2010 origin is asserted for the institution. Previous legal names include Barts and the London Charity Trustee and related charities. It is distinct from Barts Health NHS Trust, Queen Mary University of London and the separate St Bartholomew’s Hospital Charitable Fund. The principal charitable purpose is health advancement through organisational grants, research fellowships, clinical research, healthcare innovation and patient experience. Its current own public rosters identify62 people across five senior managers, ten trustees,12 other non-executive committee members and35 additional grant-panel advisers; Sarah Purdy also chairs a panel, yielding63 documented roles. Authentic own portraits are available for27 managers, trustees and non-executives, while35 additional panel biographies publish professional affiliations without portraits. Advisory roles are not employee positions or personal investment checks. The charity manages an endowment supporting grant making; official FY2025 income, expenditure and long-term investments are accounting totals, not LP fund closings or company allocations. Special Purpose Funds and grant schemes are charitable designations rather than verified venture funds. No external-LP fund vehicle or actual capital raise is established. A2019 issuer announcement identifies a joint GBP489,000 translational-research award to ResoTher Pharma and Professor Mauro Perretti’s group at Queen Mary’s William Harvey Institute for preclinical RTP026 work. The company’s allocated share, payment schedule and amount received are unpublished; the joint programme value is not attributed wholly to the company. The institutional grant link is represented separately with issuer-specific cash unknown. Its own current breast-cancer research page explicitly connects its support to the development of PharosAI, using curated NHS data to develop and test clinical AI tools. Historical own reporting also documents brain-tumour translational research and neurosurgical imaging support. These are charitable research programmes; no direct PharosAI equity participation or corporate ticket is inferred.

Team

Ajit AbrahamHealthcare Funding Advisory Panel Member

Ayo AjayiMember of Finance & Audit Committee

Catherine GodsonTrustee and Grants Committee Member

Charlotte SparrowEveryday Impact Advisory Panel Member

Claire DavisEveryday Impact Advisory Panel Member

Claire WellsScientific Review Panel Member

Craig FinchEveryday Impact Advisory Panel Member

Daniel PhillipsHealthcare Funding Advisory Panel Member

Davoud Amel-AzizpourTrustee and Chair-Elect of Finance & Audit Committee

Elizabeth SapeyGrants Committee Member

Emma EnglishFellowship Panel Member

Fiona BickleyChief Operating Officer

Fiona Miller SmithChief Executive

Frances PrennTrustee

Guang YangScientific Review Panel Member

Guy LloydHealthcare Funding Advisory Panel Member

Hannah YoungFellowship Panel Member

Hortensia GimenoHealthcare Funding Advisory Panel Member

Ian HartTrustee and Senior Independent Trustee, Chair of Investment Committee, Member of Finance & Audit Committee and Appointments & Remuneration Committee